Novel lipids and lipid nanoparticle formulations for delivery of nucleic acids
US-2015376115-A1 · Dec 31, 2015 · US
US9493400B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9493400-B2 |
| Application number | US-201314387945-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 25, 2013 |
| Priority date | Mar 30, 2012 |
| Publication date | Nov 15, 2016 |
| Grant date | Nov 15, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
This invention relates to a resolution process for the preparation of fluoroleucine alkyl esters.
Opening claim text (preview).
What is claimed is: 1. A processes for preparing a compound of formula IA: comprising the steps of: a. alkylating an imine carboxylate of formula IIA with methallyl halide to form a substituted imine of formula IIIA; b. deprotecting the substituted imine of formula IIIA with an acid to yield an amine of formula IVA; c. resolving the amine of formula IVA with a chiral protic acid selected from the group consisting of D-(+)-camphor-10-sulfonic acid, D-BOC-proline, di-p-tolyl-D-tartaric acid, N-acetyl-D-phenyl alanine and mixtures thereof, in the presence of 5-nitrosalicylaldehyde; d. fluorinating the resolved amine to yield the compound of formula IA; wherein X is H 2 SO 4 , L-tartaric acid, D-BOC proline, L-(−)-10-camphorsulfonic acid or N-acetyl-D-phenyl alanine. 2. The process of claim 1 , wherein step a. is performed in the presence of a strong base. 3. The process of claim 2 , wherein the strong base is selected from the group consisting of potassium t-butoxide, lithium t-butoxide, sodium t-butoxide, LDA, sodium hydride, n-BuLi, sec-BuLi, t-BuLi, LiHMDS, NaHMDS, KHMDS, LiTMP and mixtures thereof. 4. The process of claim 1 , wherein step a. is performed in the presence of a polar aprotic solvent. 5. The process of claim 1 , wherein the acid is selected from the group consisting of hydrochloric acid, triflic acid, sulfuric acid, p-toluenesulfonic acid, naphthalene disilfonic acid, trifluoroacetic acid and mixtures thereof. 6. The process of claim 1 , wherein step d. is performed with a fluorinating agent selected from the group consisting of Olah's reagent, HF-pyridine, HF-triethylamine, HF-Urea, HF-melamine, HF and mixtures thereof. 7. The process of claim 6 wherein the fluorinating agent is Olah's reagent. 8. The process of claim 1 , wherein the chiral protic acid is D-(+)-camphor-10-sulfonic acid. 9. A compound of formula IA. wherein X is L-Tartaric acid, D-BOC proline, L-(−)-10-camphorsulfonic acid or N-acetyl-D-phenyl alanine. 10. A compound of formula
the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups · CPC title
of a saturated carbon skeleton containing rings · CPC title
by separation of optical isomers · CPC title
of compounds containing imino groups · CPC title
the nitrogen atom of the amino group being further bound to hydrogen atoms · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.